Most patients with stage four cancer are not considered candidates for definitive radiotherapy due to the challenge of treating multiple tumors. Our breakthrough technology is challenging that and aims to treat multiple tumors, in parallel, during a single session.
Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. RefleXion will work together with chemotherapy, immunotherapy and targeted drugs for potentially better outcomes.
Lungs among most common site for metastatic tumors HAYWARD, Calif., Dec. 1, 2021 – RefleXion Medical, Inc., a therapeutic oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its biology-guided radiotherapy* (BgRT) for use in treating lung tumors. The breakthrough potential of BgRT […]
Physicians at Stanford Radiation Oncology have treated the first patient using the RefleXion X1 system. The RefleXion X1 combines high quality computed tomography (CT) imaging, known as fan-beam CT, with a linear accelerator to reduce motion artifacts that can inhibit accurate targeting of the radiation dose to a patient's tumor. According to the company, its design rotates up to 60 times faster than other linear accelerators and modulates dose delivery from 100 points per beam station.
Roughly one in eight men in the U.S. will be diagnosed with prostate cancer during their lifetime, making it the second most common cancer for men after skin cancer.1 Without using the recently approved molecular imaging method targeting PSMA during the initial staging, misdiagnosis of the correct prostate cancer stage happens in up to 50% […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.